Hormone Replacement Therapy for the Primary Prevention of Chronic Diseases
Prepared by C. N. Wathen, D. S. Feig, J. W. Feightner, B. L. Abramson, A. M. Cheung, with the Canadian Task Force on Preventive Health Care
These recommendations were finalized by the Task Force in February 2003.
| MANEUVER | RECOMMENDATION |
| Combined estrogen-progestin therapy and estrogen-only therapy for the primary prevention of chronic diseases in menopausal women. |
The CTFPHC recommends against the use of combined estrogen-progestin therapy and estrogen-only therapy for the primary prevention of chronic disease in menopausal women (D recommendation).
|
* For women who wish to alleviate menopausal symptoms using hormone replacement therapy (HRT), a discussion between the woman and her physician about the potential benefits and risks of HRT is warranted.
Link to Published Recommendation Statement
Link to Selected References list of this review
Reprinted in modified format by the Canadian
Task Force on Preventive Health Care
with permission.
Original Copyright
© 2000 Canadian Medical Association.
For any technical issues please contact: webmaster@ctfphc.org
Last modified:
September 09, 2004
